Free Trial
NASDAQ:HSIC

Henry Schein (HSIC) Stock Price, News & Analysis

$70.54
-0.67 (-0.94%)
(As of 10/3/2024 ET)

About Henry Schein Stock (NASDAQ:HSIC)

Key Stats

Today's Range
$69.72
$71.44
50-Day Range
$63.92
$73.22
52-Week Range
$60.01
$82.63
Volume
1.17 million shs
Average Volume
1.35 million shs
Market Capitalization
$9.03 billion
P/E Ratio
23.83
Dividend Yield
N/A
Price Target
$77.10
Consensus Rating
Moderate Buy

Company Overview

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Henry Schein Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
85th Percentile Overall Score

HSIC MarketRank™: 

Henry Schein scored higher than 85% of companies evaluated by MarketBeat, and ranked 176th out of 995 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Henry Schein has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 5 buy ratings, 5 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Henry Schein has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Henry Schein's stock forecast and price target.
  • Earnings Growth

    Earnings for Henry Schein are expected to grow by 10.76% in the coming year, from $4.74 to $5.25 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Henry Schein is 23.83, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 131.22.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Henry Schein is 23.83, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 128.79.

  • Price to Earnings Growth Ratio

    Henry Schein has a PEG Ratio of 2.01. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Henry Schein has a P/B Ratio of 2.14. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Henry Schein's valuation and earnings.
  • Percentage of Shares Shorted

    5.02% of the float of Henry Schein has been sold short.
  • Short Interest Ratio / Days to Cover

    Henry Schein has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Henry Schein has recently increased by 5.38%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Henry Schein does not currently pay a dividend.

  • Dividend Growth

    Henry Schein does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.02% of the float of Henry Schein has been sold short.
  • Short Interest Ratio / Days to Cover

    Henry Schein has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Henry Schein has recently increased by 5.38%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Henry Schein has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 14 news articles for Henry Schein this week, compared to 8 articles on an average week.
  • MarketBeat Follows

    1 people have added Henry Schein to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Henry Schein insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,457,726.00 in company stock.

  • Percentage Held by Insiders

    Only 1.14% of the stock of Henry Schein is held by insiders.

  • Percentage Held by Institutions

    96.62% of the stock of Henry Schein is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Henry Schein's insider trading history.

HSIC Stock News Headlines

Time to pull back the curtain for you
Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the week
Lazard Equity Franchise Portfolio Q2 2024 Commentary
See More Headlines

HSIC Stock Analysis - Frequently Asked Questions

Henry Schein's stock was trading at $75.71 at the beginning of 2024. Since then, HSIC shares have decreased by 6.8% and is now trading at $70.54.
View the best growth stocks for 2024 here
.

Henry Schein, Inc. (NASDAQ:HSIC) posted its earnings results on Tuesday, August, 6th. The company reported $1.23 earnings per share for the quarter, beating analysts' consensus estimates of $1.22 by $0.01. The firm's quarterly revenue was up .0% compared to the same quarter last year.
Read the conference call transcript
.

Henry Schein shares split on the morning of Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly issued shares were issued to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Henry Schein subsidiaries include these companies: Prism Medical Products LLC, Elite Computer Italia, Southern Anesthesia & Surgical, Marrodent, Dental Cremer, RxWorks, Dental Trey, and more.

Henry Schein's top institutional shareholders include SG Americas Securities LLC (0.36%), JLB & Associates Inc. (0.06%), Czech National Bank (0.02%) and Central Pacific Bank Trust Division (0.01%). Insiders that own company stock include James P Breslawski, Stanley M Bergman, Gerald A Benjamin, Michael S Ettinger, Bradford C Connett, Lorelei Mcglynn, Mark E Mlotek, David B Brous Jr, Walter Siegel, Philip A Laskawy, Kurt P Kuehn and Scott Philip Serota.
View institutional ownership trends
.

Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Henry Schein investors own include Alibaba Group (BABA), Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA) and QUALCOMM (QCOM).

Company Calendar

Last Earnings
8/06/2024
Today
10/03/2024
Next Earnings (Confirmed)
11/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical & hospital equipment
Sub-Industry
Health Care Distributors
Current Symbol
NASDAQ:HSIC
CUSIP
80640710
Employees
25,000
Year Founded
1932

Price Target and Rating

Average Stock Price Target
$77.10
High Stock Price Target
$86.00
Low Stock Price Target
$65.00
Potential Upside/Downside
+9.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
12 Analysts

Profitability

Net Income
$416 million
Pretax Margin
3.62%

Debt

Sales & Book Value

Annual Sales
$12.49 billion
Cash Flow
$6.56 per share
Book Value
$33.01 per share

Miscellaneous

Free Float
126,591,000
Market Cap
$9.01 billion
Optionable
Optionable
Beta
0.86

Social Links


This page (NASDAQ:HSIC) was last updated on 10/3/2024 by MarketBeat.com Staff
From Our Partners